Zhongchao Inc. (ZCMD)
NASDAQ: ZCMD · Real-Time Price · USD
1.130
-0.010 (-0.88%)
At close: Sep 18, 2025, 4:00 PM EDT
1.160
+0.030 (2.65%)
After-hours: Sep 18, 2025, 4:50 PM EDT
Zhongchao Revenue
In the year 2024, Zhongchao had annual revenue of $15.86M, down -18.37%. Zhongchao had revenue of $7.52M in the half year ending December 31, 2024, with 9.63% growth.
Revenue (ttm)
$15.86M
Revenue Growth
-18.37%
P/S Ratio
0.37
Revenue / Employee
$142,926
Employees
111
Market Cap
28.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.86M | -3.57M | -18.37% |
| Dec 31, 2023 | 19.43M | 5.28M | 37.33% |
| Dec 31, 2022 | 14.15M | -2.15M | -13.16% |
| Dec 31, 2021 | 16.30M | -1.69M | -9.41% |
| Dec 31, 2020 | 17.99M | 3.11M | 20.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ZCMD News
- 1 year ago - Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications - PRNewsWire
- 1 year ago - Zhongchao Inc. Announces 1-for-10 Share Consolidation - PRNewsWire
- 1 year ago - Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments - PRNewsWire
- 2 years ago - Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day - PRNewsWire
- 2 years ago - Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients - PRNewsWire
- 2 years ago - Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management - PRNewsWire
- 2 years ago - Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education - PRNewsWire
- 2 years ago - Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment - PRNewsWire